EHang Holdings Ltd - ADR vs Zoetis Inc — how do they compare? EHang Holdings Ltd - ADR trades at $5.34 (market cap $414.87M), while Zoetis Inc trades at $77.27 (market cap $31.25B). The key difference: Zoetis Inc is far larger — about 75.3× EHang Holdings Ltd - ADR's market cap, and Zoetis Inc pays a 2.84% dividend while EHang Holdings Ltd - ADR pays none. Which is the better fit depends on your goals.
| EH | ZTS | |
|---|---|---|
Market Cap | $414.87M | $31.25B |
Sector | Industrials | Health |
52-Week High | $19.99 | $156.76 |
52-Week Low | $5.41 | $71.91 |
Enterprise Value | $354.54M | $38.54B |
Dividend Yield | — | 2.84% |
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $5.41, down 0.73% on the day, with technical indicators showing bearish momentum and mixed sentiment. The company reported Q1 2026 revenue of $418 million, flat year-over-year but sharply lower than the prior quarter due to delivery timing. Despite a strong gross margin of 61.53%, the company continues to post significant net losses (-$276 million in 2025) with negative ROE and ROA. Recent news highlights both operational progress in eVTOL certification and a $30 million share repurchase program announced in June 2026.
The outlook remains challenging with persistent losses and high cash burn, though analyst consensus suggests modest upside to the $6.97 price target. Key risks include execution on commercialization, competitive pressures in the air mobility sector, and reliance on financing activities to fund operations. The stock presents speculative appeal for investors betting on long-term eVTOL adoption, but requires careful risk management given the current financial profile.
Zoetis (ZTS) trades at $77.13, up 4.12% in the last session, with a bearish technical signal from moving averages. The company reported strong 2025 results, including $9.47B revenue and $2.67B net income, with high profitability margins. Recent news highlights a securities class action lawsuit and the launch of Lenivia in Canada and the EU. Cash flow improved to a positive $325M in 2025, though net cash flow is projected to decline in 2026.
The stock presents a mixed outlook: strong fundamentals and a consensus price target of $101.43 suggest upside, but legal risks and bearish technicals pose near-term headwinds. Earnings momentum is key, with Q2 2026 results critical after a Q1 miss. Institutional sentiment is cautious despite no sell ratings.
Trailing returns across standard periods
Latest headlines on both assets
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →